Weekly Digest – August 2026 Weekly Digest – August 2026 20 August 2026: Akiram Therapeutics and ITM signed a Lu-177 supply agreement to support AKIR001 development in Solid tumors Akiram Therapeutics and ITM Isotope Technologies Munich have signed an agreement […]
Weekly Digest – July 2026 Weekly Digest – July 2026 17 July 2026: NMPA accepts New Drug Application for Trastuzumab Envedotin injection CSPC Pharmaceutical Group announced that China’s NMPA has accepted the new drug application for Trastuzumab envedotin injection, a […]
Weekly Digest – July 2026 Weekly Digest – July 2026 18 July 2026: Medilink announces NMPA acceptance of marketing application for Tam-Peli in 3L+ NPC MediLink Therapeutics announced that China’s NMPA has accepted the new drug application for Tam-Peli, its […]
Weekly Digest – July 2026 Weekly Digest – July 2026 22 July 2026: Samsung Bioepis enters into a commercial license agreement with IntoCell for an ADC candidate Samsung Bioepis has entered into a commercial license agreement with IntoCell for SBE303, […]
Weekly Digest – July 2026 Weekly Digest – July 2026 13 July 2026: VERAXA Biotech and Ardigen collaborate to accelerate AI-enabled BiTAC pipeline development VERAXA Biotech has entered an AI-enabled drug discovery collaboration with Ardigen to accelerate the development of […]
Weekly Digest – July 2026 Weekly Digest – July 2026 15 July 2026: Protina partners with Onconic Therapeutics on next-generation cancer drugs Proteina and Onconic Therapeutics have entered a strategic collaboration to develop next-generation oncology therapies, combining Proteina’s antibody engineering […]
Weekly Digest – July 2026 Weekly Digest – July 2026 09 July 2026: RyboDyn partners with U.S department of war to advance AI-discovered ADC therapies for Lung cancer RyboDyn received a $1.3 million grant from the U.S. Department of War […]
Weekly Digest – July 2026 Weekly Digest – July 2026 26 June 2026: Datroway recommended for approval in the EU as 1st-line treatment for patients with metastatic TNBC who are not candidates for immunotherapy AstraZeneca and Daiichi Sankyo’s Datroway has […]
Weekly Digest – July 2026 Weekly Digest – July 2026 02 July 2026: FDA alignment to advance ProstACT Global phase 3 trial Telix Pharmaceuticals has reached alignment with the U.S. FDA to advance the ProstACT Global phase 3 trial of […]
Weekly Digest – June 2026 Weekly Digest – June 2026 22 June 2026: Lonza and InduPro announce licensing agreement to advance next-generation ADC therapeutics Lonza and InduPro have entered into a licensing agreement to advance next-generation antibody-drug conjugate therapeutics, providing […]
